Cargando…

Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian cancer

Detalles Bibliográficos
Autores principales:	van Asperen, C J, Jacobi, C E, de Bock, G H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361986/ https://www.ncbi.nlm.nih.gov/pubmed/15785743 http://dx.doi.org/10.1038/sj.bjc.6602489

Ejemplares similares

Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK
por: Antoniou, A C, et al.
Publicado: (2005)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
por: Møller, Nanna Bæk, et al.
Publicado: (2023)

Author Correction: Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
por: Møller, Nanna Bæk, et al.
Publicado: (2023)

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study
por: Brédart, Anne, et al.
Publicado: (2022)

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
por: Mavaddat, Nasim, et al.
Publicado: (2023)

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models
por: Ming, Chang, et al.
Publicado: (2019)

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
por: Ståhlbom, Anne Kinhult, et al.
Publicado: (2011)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
por: MacInnis, R J, et al.
Publicado: (2013)

Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model
por: Lee, Andrew J., et al.
Publicado: (2016)

Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations
por: Ming, Chang, et al.
Publicado: (2020)

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study
por: Yang, Xin, et al.
Publicado: (2022)

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
por: Lakeman, Inge M. M., et al.
Publicado: (2020)

Clinical software development for the Web: lessons learned from the BOADICEA project
por: Cunningham, Alex P, et al.
Publicado: (2012)

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
por: Brédart, Anne, et al.
Publicado: (2017)

Remarks on sentinel node biopsy in head and neck cancer
por: Kovács, A F
Publicado: (2005)

Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations
por: de Silva, Tania Samantha, et al.
Publicado: (2018)

Remarks on Myeloid Sarcoma in Children
por: Gözdaşoğlu, Sevgi
Publicado: (2019)

Reply: Remarks on sentinel node biopsy in head and neck cancer
por: Hoft, S, et al.
Publicado: (2005)

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer
por: de Graeff, P, et al.
Publicado: (2007)

Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition
por: Seymour, C B, et al.
Publicado: (2003)

Remarks in metformin and sleep disorders in diabetic patients
por: Shohrati, Majid, et al.
Publicado: (2012)

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Genetic variation of allergic disease is associated with the susceptibility to COVID-19
por: Xu, Yaqi, et al.
Publicado: (2022)

A Remarkable Epitaph
por: Ashton, Algernon
Publicado: (1902)

Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry
por: Pal Choudhury, Parichoy, et al.
Publicado: (2021)

Remarkable improvement of primary orthostatic tremor using perampanel
por: Grobe-Einsler, Marcus, et al.
Publicado: (2020)

CYP1A1 M2 (A2455G) Polymorphism with Susceptibility to Breast Cancer
por: Joob, Beuy, et al.
Publicado: (2020)

Recurrent intrathoracic solitary fibrous tumor: Remarkable response to radiotherapy
por: Cubuk, Sezai
Publicado: (2015)

Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
por: Benguerfi, S., et al.
Publicado: (2022)

Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients
por: Kwong, Ava, et al.
Publicado: (2012)

Diagnosis of primary ovarian cancer
por: Wiwanitkit, Viroj
Publicado: (2010)

Minoxidil Poisoning: A Case of Refractory Shock with Remarkable ECG Changes
por: Dash, Snehangsh, et al.
Publicado: (2023)

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence
por: Lee, Andrew, et al.
Publicado: (2022)

Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance
por: Finsterer, Josef, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_coo59i7cmpk58nn78nuf3soohl